All-cause mortality is decreased in women undergoing annual mammography before breast cancer diagnosis

AJR. American Journal of Roentgenology
Jessica M EngelAdedayo A Onitilo

Abstract

The value of annual mammography remains an area of debate because of concerns regarding risk versus benefit. The potential for harm due to overdiagnosis and treatment of clinically insignificant cancers may not be captured by breast cancer-specific mortality. Instead, we examined all-cause mortality as a function of missed annual mammography examinations before breast cancer diagnosis. Primary breast cancer cases diagnosed in the Marsh-field Clinic Health System from 2002 through 2008 were identified for retrospective review, and whether annual mammography examinations had been performed in the 5 years before diagnosis was assessed. Analyses were performed on 1421 women with breast cancer. After adjustment of data for age, comorbidity status, a family history of breast cancer, insurance status, medical encounter frequency, and the calendar year, women who had missed any of the previous five annual mammography examinations had a 2.3-fold increased risk of all-cause mortality compared with subjects with no missed mammography examinations (hazard ratio=2.28; 95% CI, 1.58-3.30; p<0.0001). Additionally, an analysis by the number of missed annual mammography examinations showed a progressive increase in hazard as the number of missed...Continue Reading

References

Jul 1, 1994·Cancer·S Shapiro
Feb 16, 2000·Lancet·H J de Koning
Feb 16, 2000·Lancet·P C Gøtzsche, O Olsen
Mar 7, 2000·Lancet·S MossM J Quinn
Mar 7, 2000·Lancet·L Nyström
Mar 7, 2000·Lancet·C HayesJ Buttimer
Feb 13, 2001·British Journal of Cancer·J McCannUNKNOWN East Anglia Breast Screening Programme
Jan 11, 2002·Lancet·S W DuffyR A Smith
Feb 7, 2002·Journal of the National Cancer Institute·William C BlackH Gilbert Welch
Jun 6, 2002·Journal of the National Cancer Institute·Mitchell H Gail, Hormuzd A Katki
Jul 26, 2003·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S W DuffyH H Chen
Jul 31, 2003·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·A R JensenaJ Overgaard
Dec 9, 2003·The Breast : Official Journal of the European Society of Mastology·Pekka J KlemiHans Helenius
Feb 18, 2004·The Breast : Official Journal of the European Society of Mastology·S W Duffy
Apr 13, 2004·International Journal of Epidemiology·David A FreedmanJames M Robins
Aug 5, 2004·British Journal of Cancer·R RoychoudhuriH Møller
Aug 5, 2004·British Journal of Cancer·J FracheboudUNKNOWN National Evaluation Team for Breast cancer screening (NETB)
Jun 28, 2006·Clinical Breast Cancer·Henry G Kaplan, Judith A Malmgren
Oct 22, 2009·JAMA : the Journal of the American Medical Association·Laura EssermanIan Thompson
Oct 15, 2011·BMJ : British Medical Journal·Robert J C Steele, David H Brewster
Oct 26, 2011·Archives of Internal Medicine·Timothy J Wilt, Melissa R Partin
Oct 26, 2011·Archives of Internal Medicine·H Gilbert Welch, Brittney A Frankel
Apr 25, 2012·Annals of Surgical Oncology·Timothy I Carter, James J Reilly
May 16, 2012·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·Laia DomingoMaria Sala
Sep 8, 2012·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Carolyn NicksonAnne M Kavanagh
Nov 8, 2012·Journal of Medical Screening·Mireille BroedersUNKNOWN EUROSCREEN Working Group
Nov 8, 2012·Journal of Medical Screening·S M MossUNKNOWN Euroscreen Working Group
Nov 8, 2012·Journal of Medical Screening·Sisse NjorUNKNOWN Euroscreen Working Group
Nov 23, 2012·The New England Journal of Medicine·Archie Bleyer, H Gilbert Welch
Dec 25, 2012·Breast Cancer Research and Treatment·I D Nagtegaal, S W Duffy
Apr 2, 2013·Health Technology Assessment : HTA·M BondC Hyde
Jun 1, 2013·JAMA : the Journal of the American Medical Association·Michael G Marmot
Aug 21, 2013·AJR. American Journal of Roentgenology·Adedayo A OnitiloSuhail A Doi

❮ Previous
Next ❯

Citations

Oct 28, 2016·Breast Cancer : the Journal of the Japanese Breast Cancer Society·Shifu TangJianqing Yang
Dec 25, 2015·AJR. American Journal of Roentgenology·Andrew B Rosenkrantz, Vinay Prabhu
Oct 21, 2016·Einstein·Ricardo Soares de Sant'AnaAltacílio Aparecido Nunes
Aug 4, 2018·Radiographics : a Review Publication of the Radiological Society of North America, Inc·Yiming GaoLinda Moy
Jul 15, 2015·Journal of breast cancer·Zisun KimUNKNOWN Korean Breast Cancer Society
Oct 25, 2017·AJR. American Journal of Roentgenology·Stamatia Destounis, Amanda Santacroce
Feb 29, 2020·Journal of Family Medicine and Primary Care·Sulaiman Abdullah AlshammariAbdullah Mohammed Alshahrani
Mar 16, 2016·Physics in Medicine and Biology·Gijs A G M HendriksChris L de Korte
Nov 23, 2019·SA Journal of Radiology·Shirley Lipschitz
Jun 23, 2021·Journal of the American College of Radiology : JACR·Debra L MonticcioloDana Smetherman

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)
Adedayo A OnitiloSuhail A R Doi
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology
Lene MellemkjærJørgen H Olsen
© 2021 Meta ULC. All rights reserved